rxstat › Shortages › Ravulizumab

Ravulizumab shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ravulizumab products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 1
Reports on file
1

Reports by product

Discontinued
ULTOMIRIS
10MG · SOLUTION · ALEXION PHARMA GMBH
DIN 02491559

What's happening

One or more Ravulizumab products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Recent changes

Common questions

When will Ravulizumab be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ravulizumab in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Widespread shortageApremilast2 of 3 reported products affectedPartial shortageAdalimumab1 of 7 reported products affectedPartial shortageApremilast Apremilast Apremilast1 of 1 reported products affected · est. return Aug 28, 2026Partial shortageBasiliximab1 of 1 reported products affectedPartial shortageCyclosporine1 of 8 reported products affected · est. return Jul 30, 2027Partial shortageFingolimod3 of 8 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.